Official blog
Compliance-aware guides and brand updates for adult consumers.
Page 10 of 36 / 848 articles
The FDA's tobacco regulatory framework is rigid—every product must go through the same PMTA process, regardless of risk. Regulatory flexibility—distinguishing between products based on risk—would save lives. Congress would need to change the law.
The decision to switch from smoking to vaping is not just pharmacological. It's psychological: identity, satisfaction, social norms, and the perceived risk of the alternative. Understanding the psychology of switching is key to making it happen more often.
The technology of quitting has evolved from willpower alone to pharmacotherapy to digital interventions. Each generation of technology has improved quit rates. The next generation—AI, wearables, predictive analytics—could transform cessation.
The tobacco control workforce is demographically homogeneous, ideologically cohesive, and professionally invested in the abstinence framework. Understanding who they are is essential to understanding why nicotine policy looks the way it does.
Flavor bans don't eliminate the demand for flavored vaping products. They eliminate the legal supply. The demand migrates to DIY mixing, cross-border purchasing, and illicit sources. The flavor black market is a predictable—and predicted—consequence.
A growing movement of shareholder activists is pushing nicotine companies to accelerate their transition away from cigarettes. The activists are using the tools of corporate governance—proxy votes, resolutions, engagement. The impact is modest but growing.
The epidemiological evidence is consistent: smokers have lower rates of Parkinson's disease. The mechanism appears to be nicotine's neuroprotective effect. Research on nicotine for cognitive decline is ongoing. The implications are ethically complex.
Correctional officers smoke at elevated rates. The job is stressful, the environment is (now) smoke-free, and the culture of corrections has historically been tolerant of smoking. The correctional officer's smoking is a window into occupational health in the carceral system.
College students are sophisticated consumers of information—and they're skeptical of simplistic prevention messages. Reaching them requires honesty about nicotine's effects (the cognitive benefits, not just the risks) and respect for their capacity to make decisions.
The search for alternative crops to replace tobacco has been ongoing for decades. Some alternatives work—in specific regions, under specific conditions. Most don't pay as well as tobacco. The economic gap is the central challenge of the transition.
The precautionary principle demands near-certainty before endorsing reduced-risk products. The same standard is never demanded of the status quo. The asymmetry in standards of evidence is the central philosophical tension in nicotine policy.
Adolescents are developmentally wired to prioritize peer influence over adult authority. The most effective youth nicotine interventions work with this developmental reality, not against it. Peer-led cessation is more effective than adult-delivered programs.
NRT and prescription cessation medications are effective—when taken as prescribed. Adherence rates are low. Smokers stop using their patches early, skip doses of varenicline, and abandon their quit plans. Understanding why is key to improving outcomes.
The 2009 Tobacco Control Act gave cigarette companies partial immunity from liability for past conduct. The immunity is controversial—and it may be extended to reduced-risk products. The liability question shapes the industry's willingness to innovate.
Vaping in the UK is a public health tool. In the US, it's a regulatory battleground. In Japan, it barely exists—heated tobacco dominates. Vape culture is not universal. It's shaped by policy, history, and consumer preferences.
The major nicotine companies are on an acquisition spree—buying vaping startups, pouch manufacturers, and technology platforms. The strategy is to control the reduced-risk market before it matures. The consolidation has implications for innovation and access.
Animal studies of adolescent nicotine exposure show real neurobiological effects. Translating those effects to human policy requires assumptions that the studies themselves cannot validate. The gap between animal evidence and human policy is where the debate lives.
Before indoor smoking bans, bartenders were among the most heavily exposed workers to secondhand smoke. The bans transformed their health. The story of the bartender is a case study in the power of occupational health regulation.
Teenagers who want to quit nicotine are unlikely to call a quitline or visit a counselor. They are likely to use digital tools—apps, text programs, chatbots. Developing youth-centered digital cessation is a public health priority that is severely underfunded.
Illicit cigarettes follow routes as established as any legitimate trade: from low-tax jurisdictions to high-tax ones, through free-trade zones and porous borders. The smuggling routes are well-mapped. The enforcement is perpetually one step behind.
New York's cigarette tax is among the highest in the US. Pennsylvania's is among the lowest. The result: a cross-border trade that undermines both states' policies. Tax harmonization is the obvious solution—and politically impossible.
Motivational interviewing is a counseling technique that helps smokers resolve their ambivalence about quitting—without pressure, without judgment, without 'you should.' The evidence for MI is strong. Its use in routine care is minimal.
Most quit attempts end in relapse. A relapse prevention plan—identifying high-risk situations, developing coping strategies, and planning for lapses—reduces the risk. The plan is more important than the quit method.
Nicotine consumer advocacy was once driven by personal testimony—'vaping saved my life.' It's increasingly driven by evidence—systematic reviews, population data, and policy analysis. The shift from testimony to evidence is transforming consumer advocacy's credibility.
Products
Select a product to view details, highlights, and technical specifications.
